SciSparc SPRC
NASDAQ SPRC
$0.39 -0.03 (-6.09%)
As of: Nov 10, 2026 · 1:22 PM EST

SciSparc (SPRC) Convertible Debt (2018 - 2026)

Updated

SciSparc (SPRC) reported Convertible Debt of $2.34 million for Q2 2026, up 12.0% from $2.09 million a year earlier.

Analysis

SciSparc (SPRC) Convertible Debt (2018 - 2026) Analysis & Trends

At the end of FY2025, SciSparc posted Convertible Debt of $2.21 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 SciSparc 49,990.67 -14.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Jun 30, 2025 2.09 Mn
Jun 30, 2019 993,000.00
Dec 31, 2018 779,000.00
Jun 30, 2018 705,000.00
API Access

SciSparc Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SPRC&period=max&api_key=YOUR_API_KEY